Clinical trial
Screen and Treat for Cervical Cancer Prevention
NCT00233727 · Columbia University, Other · Terminated
Key facts
| NCT number | NCT00233727 |
|---|---|
| Title | Screen and Treat for Cervical Cancer Prevention |
| Official title | Safety and Efficacy of Two Screen-and-Treat Approaches for the Prevention of Cervical Cancer |
| Acronym | SAT |
| Lead sponsor | Columbia University, Other |
| Collaborators | Bill and Melinda Gates Foundation EngenderHealth University of Cape Town |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cervical Cancer |
| Intervention type | Procedure |
| Interventions | HPV DNA Testing + Cryosurgery, VIA + Cryosurgery |
| Enrollment | 7,123 |
| Start date | Jan 1, 2000 |
| Primary completion | Apr 1, 2006 |
| Completion | May 1, 2013 |
| First posted | Oct 6, 2005 |
| Last update posted | Jul 9, 2015 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: